Similar articles

• Correction: The increasing incidence of stage IV cervical cancer in the USA: what factors are related?.

  [No authors listed] [No authors listed] Int J Gynecol Cancer. 2023 Feb 6;33(2):317-318. doi: 10.1136/ijgc-2022-003728corr2. Int J Gynecol Cancer. 2023. PMID: 36746508 No abstract available.
• Correspondence on "The increasing incidence of stage IV cervical cancer in the USA: what factors are related?" by Francoeur et al.

  Datta GD, Mayrand MH, Glenn BA. Datta GD, et al. Int J Gynecol Cancer. 2023 Jan 3;33(1):136. doi: 10.1136/ijgc-2022-004066. Int J Gynecol Cancer. 2023. PMID: 36307146 No abstract available.
• The increasing incidence of stage IV cervical cancer in the USA: what factors are related?

  Francoeur AA, Liao CI, Caesar MA, Chan A, Kapp DS, Cohen JG, Salani R, Chan JK. Francoeur AA, et al. Int J Gynecol Cancer. 2022 Sep 6;32(9):1115-1122. doi: 10.1136/ijgc-2022-003728. Int J Gynecol Cancer. 2022. PMID: 35981903
• [Chemotherapy in the management of advanced or high risk cervical cancer].

  Shimizu Y. Shimizu Y. Gan To Kagaku Ryoho. 1995 Aug;22(9):1152-62. Gan To Kagaku Ryoho. 1995. PMID: 7661566 Review. Japanese.
• Clinical statistics of gynecologic cancers in Japan.

  Yamagami W, Nagase S, Takahashi F, Ino K, Hachisuga T, Aoki D, Katabuchi H. Yamagami W, et al. J Gynecol Oncol. 2017 Mar;28(2):e32. doi: 10.3802/jgo.2017.28.e32. Epub 2017 Feb 10. J Gynecol Oncol. 2017. PMID: 28198168 Free PMC article. Review.